This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

CombiMatrix Names Mark McDonough Chief Commercial Officer

IRVINE, Calif., Aug. 23, 2012 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company performing DNA-based testing services for cancer and developmental disorders, today announced that veteran sales and diagnostic executive Mark McDonough has been named Chief Commercial Officer, effective immediately. McDonough, 43, will report directly to CombiMatrix CEO R. Judd Jessup.

McDonough, a resident of San Diego, has more than 20 years of sales experience and business development with a specialty in diagnostics. He has experience working in a variety of business environments, including start-ups, emerging companies, and large Fortune 500 companies including EMC and Lab Corp.

"Mark has shown that he can build and lead a sales team, and craft a successful commercial strategy, which is critical as we continue to take advantage of the positive momentum we have built in our pre-natal and pediatric businesses," Jessup said. "2012 has ushered in important clinical and commercial catalysts that have led CombiMatrix to shift its focus, and we are now redeploying our selling organization squarely on the developmental markets, where we believe we have a greater opportunity for growth."

Jessup concluded, "We believe we have already made solid progress in redeploying our resources in the past few months as we seek to take advantage of our unique position in the developmental segment. Mark's leadership will be instrumental in helping us further optimize the organization and approach as we move those efforts forward. We are very pleased to have an executive of Mark's caliber join our team."

McDonough was most recently Vice President, Sales, Customer Service and Training at Redwood City, CA-based Pathwork Diagnostics, a position he held since 2008. He demonstrated the ability to grow sales each year, served on the executive steering committee and was actively involved in all strategic commercial initiatives. Prior to that, from 2002-2008, McDonough worked for Irvine, CA-based USLabs/Dianon (when USLabs was acquired by LabCorp) and ultimately became Vice President of Sales. During his time there, he led a 56-member sales team, led various sales and marketing initiatives and helped drive a turnaround effort during a management overhaul.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.74 0.00%
GOOG $693.01 0.00%
FB $117.58 0.00%
TSLA $240.76 0.00%
YHOO $36.60 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs